MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Scopolamine-induced Tardive Dyskinesia: A Case Report

    H. Deville, M. Christie (Houston, USA)

    Objective: To present a case of scopolamine-related Tardive Dyskinesia (TD) and review the documented anticholinergic-associated cases of TD and the underlying pathophysiology responsible for TD.…
  • 2025 International Congress

    Physical, Mental, and Socioemotional Functional Improvement Following Valbenazine Treatment for TD: a Case Series

    R. Bera, J. Nedzesky, I. Gandayuwana, D. Winkelman, D. Vanderhoef, M. Bron, M M. Perez-Rodriguez (San Diego, USA)

    Objective: Describe clinical characteristics and changes in mental, socioemotional, and physical domains of individuals with tardive dyskinesia (TD) after valbenazine (VBZ) treatment. Background: Prior research…
  • 2025 International Congress

    Cerebellar Syndrome and Parkinsonism Associated with Acquired Hepatocerebral Degeneration with Unusual Findings on Neuroimaging.

    R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)

    Objective: To present a clinical case of cerebellar syndrome and parkinsonism linked to acquired hepatocerebral degeneration exhibiting atypical radiological abnormalities. Background: Acquired hepatocerebral degeneration (AHCD)…
  • 2025 International Congress

    DPPX Autoimmune Encephalitis Presenting with Chorea

    T. Le, S. Pradeep (Houston, USA)

    Objective: To report a case of a rare autoimmune disorder associated with dipeptidyl-peptidase-like protein- 6 (DPPX) antibodies, highlighting its classical features, diagnostic challenges, and therapeutic…
  • 2025 International Congress

    Neuroprotective Effects of Co-Administered Hesperetin and Resveratrol Nanoparticles on Oxidative Stress and Neurobehavioral Deficits in Parkinson’s Disease

    R. Rajput, S. Verma (Agra, India)

    Objective: This study aimed to evaluate the therapeutic potential of solid lipid nanoparticles (SLNs) containing hesperetin (HE-SLN), resveratrol (RE-SLN), and their co-administration (HE-RE-SLN) in combating…
  • 2025 International Congress

    Bridging the Care Gap for Individuals with Drug-Induced Movement Disorders Using Telemedicine: A Randomized Pilot Study

    E. Houston, A. Kennedy, T. Rabinowitz, G. Rose, J. Boyd (Burlington, USA)

    Objective: Our goal was to evaluate the feasibility, effectiveness, and acceptability of a remote consultation with a movement disorder neurologist to patients suspected to have…
  • 2025 International Congress

    Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge

    RAM. Carandang, P. Panyakeaw (Bangkok, Thailand)

    Objective: To highlight the diagnostic complexities of functional movement disorders (FMD) in Parkinson’s disease (PD) and the role of neurophysiological studies in differentiating functional overlay…
  • 2025 International Congress

    A Cross-sectional Gender Gap Meta-analysis in Movement Disorders Publishing Field

    D. Garg, Z. Aldaajani, M. Auffret, T. Capato, M. Picillo, C. Trenkwalder, L. Ali, M. Armstrong, M. Bruno, V. Bruno, E. Minakawa, W. Kamel, S. Fox, D. Olszewska (New Delhi, India)

    Objective: To assess whether there is a gender gap in academic publishing within the field of movement disorders. Background: The underrepresentation of women in academia…
  • 2025 International Congress

    Observations and Strategies for Improving Recruitment and Retention of Underrepresented Populations in Movement Disorders Clinical Research Trials Conducted in a Tertiary Research Site

    I. Saraf, P. Agarwal, L. Patron (Kirkland, USA)

    Objective: To observe the improvement in one tertiary clinical site of the recruitment of underrepresented populations with a focus on the Asian demographic and note…
  • 2025 International Congress

    The Role of the Immune System in Dystonia: Insights from HLA genotyping

    M. Lindloge, L. Scorr, B. Laabs, D. Ellinghaus, A. Franke, H. Jinnah, C. Klein, K. Lohmann (Altanta, USA)

    Objective: To characterize the association between Human Leukocyte Antigen (HLA) alleles and dystonia. Background: Dystonia is widely recognized to have great etiologic heterogeneity. A complex…
  • « Previous Page
  • 1
  • …
  • 289
  • 290
  • 291
  • 292
  • 293
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley